title: [The association of hyperinsulinemia with cardiovascular risk and cancer poses new challenges in the treatment of the insulin resistance type 2 diabetes patient].
abstract: Hyperinsulinemia has been associated with cardiovascular risk, both independently and by facilitating the development of other cardiovascular risk factors. It has also been associated by different routes with increased cancer risk. Thus, this makes it a priority to identify and treat the hyperinsulinemic patient early in order to delay or prevent cardiovascular risk and the development of type 2 diabetes mellitus (T2DM) and certain types of cancer. A new strategy is needed for the treatment of hyperglycemia in these patients, whose primary objective would be to achieve weight loss, reduce insulin resistance and thereby hyperinsulinemia. That is, prescribing insulin secretors and insulin should be used with caution in these patients.
authors.affiliation: Unitat d́Endocrinologia, Servei de Medicina Interna, Hospital Universitari de ĹEsperit Sant, Santa Coloma de Gramenet, Barcelona, España. Electronic address: anubiola@hes.scs.es.
authors.forename: Andreu
authors.initials: A
authors.lastname: Nubiola
authors.affiliation: Unitat d́Endocrinologia, Servei de Medicina Interna, Hospital Universitari de ĹEsperit Sant, Santa Coloma de Gramenet, Barcelona, España.
authors.forename: Marga
authors.initials: M
authors.lastname: Ferrer
authors.affiliation: Unitat de Nutrició, PAMEM (IMAS), Barcelona, España.
authors.forename: Imma
authors.initials: I
authors.lastname: Remolins
mesh_terms: D002318:Cardiovascular Diseases; D003924:Diabetes Mellitus, Type 2; D006801:Humans; D006946:Hyperinsulinism; D007333:Insulin Resistance; D009369:Neoplasms; D012307:Risk Factors
keywords: Cancer; Cardiovascular; Cáncer; Diabetes tipo 2; Hiperinsulinemia; Hyperinsulinemia; Insulin resistance; Insulinorresistencia; Type 2 diabetes